Especially Europe and India should consider approving academic center CAR-T manufacture and administration with appropriate accreditation. This will not only be much less expensive ($2000 in India or $30,000 in EU), but also more effective. Mohamad Mohty marivi mateos Tom Martin

gaganprakash Tata Memorial Hospital Srivishnu Amit Joshi Vedang Murthy Santosh Menon Amandeep Arora TMH Medical Oncology Alumni Congrats gaganprakash on this important work highlighting practice patterns and challenges in care of LABC Tata Memorial Hospital

gaganprakash Tata Memorial Hospital Srivishnu Amit Joshi Vedang Murthy Santosh Menon Amandeep Arora TMH Medical Oncology Alumni Impressive : 62% received neoadjuvant chemotherapy - once again showing the importance of receiving #bladdercancer care at high volume cancer center! IBCG Philippe spiess Roger Li Guru P. Sonpavde, MD Shilpa Gupta Prof Nikhil Vasdev Andrea Necchi Dipen J Parekh, M.D. Dr Ravimohan

Great work by gaganprakash and Srivishnu. Systemic chemo imp. in locally advanced #bladdercancer. When you give it is wrt RCIC is secondary. It's OK not to push NACT in patients with obstructive uropathy. Srivishnu, great to see an idea in JC transform to a full paper.

Another one from Tata Memorial Hospital Uro-oncology. Upfront cystectomy followed by adjuvant chemo instead of NACT f/b surgery is a valid option in select patients. Patients need to receive both local and systemic therapy. The sequence need not be rigid.

Operating, learning, teaching, partying. MASOCON-23 had it all. We had some of the stalwarts in the field operating live and engaging with a lively audience at Manipal. Shailesh V. Shrikhande Manish S Bhandare Naveena AN Kumar Hoping to see you all at MASOCON-24!

Hello friends, this time we are coming with theme based on exclusively on Uses Of Robotics in certain GI field by pioneers in Robotics in India. join us ROBOTICS - A New Era in Surgery on 9th June....us02web.zoom.us/meeting/regist…

Outcomes of extended TME in locally advanced rectal cancer. onlinelibrary.wiley.com/doi/10.1111/co…

Like the Orcs dying in the thousands!!

Purple cap and Orange cap cleansed by white cap!!

linkedin.com/posts/dr-srivi…

Superb efforts in generating collaborative evidence for a “new” surgical innovation! Kudos 👍🏻

Congratulations, Praggnanandhaa. Great achievement at a very young age. Never mind the nail-biting final loss. You gave it everything! #FIDEWorldCup

linkedin.com/posts/dr-srivi…

Join us to discuss the fine print in the GASTRIPEC-1 trial. Should it change practice? INDEPSO Manish S Bhandare Peritoneal Surface Oncology Group International Andreas Brandl Pompiliu Piso Beate Rau Paul H Sugarbaker glen naoual bakrin Olivia Sgarbura Alvaro Arjona Delia Cortés Guiral Aditi Bhatt sanket sharad mehta

We wrapped up 2023 with a brilliant discussion on the GASTRIPEC 1 Trial. Grateful to Mufaddal Kazi, Manish S Bhandare, Aditi Bhatt, Dr Aruna Prabhu & Prof Ramakrishnan for their inputs & to all of you who joined in !!

linkedin.com/posts/dr-srivi…

India has really revolutionised the healthcare system. 1. Radical nephrectomy is now cheaper than simple nephrectomy. 2. Adrenalectomy & partial nephrectomy will not cost you more than a simple nephrectomy. 3. Just pay 5k extra and get it done laparoscopically too!